/GDNSF
GDNSF Stock - Goodness Growth Holdings, Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.45+0.00%
52
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).49
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.63
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+-0.5%upside
Target: $0.45
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for GDNSF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.45 – $0.46
TARGET (TP)$0.45
STOP LOSS$0.42
RISK/REWARD1:-0.1
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.42
52W High$0.45
52W Low$0.45
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $99.38M | $88.13M | $74.63M | $54.45M | $49.21M |
| Gross Profit | $50.77M | $44.10M | $28.41M | $19.80M | $17.13M |
| Gross Margin | 51.1% | 50.0% | 38.1% | 36.4% | 34.8% |
| Operating Income | $13.56M | $10.58M | $-6,939,000 | $-20,482,000 | $-23,043,000 |
| Net Income | $-28,008,000 | $-25,547,000 | $-42,457,000 | $-33,690,000 | $-22,942,000 |
| Net Margin | -28.2% | -29.0% | -56.9% | -61.9% | -46.6% |
| EPS | $-0.16 | $-0.19 | $-0.33 | $-0.27 | $-0.24 |
Company Overview
Goodness Growth Holdings, Inc. operates as a physician-led cannabis company in the United States. The company cultivates cannabis in environmentally friendly greenhouses; manufactures pharmaceutical-grade cannabis extracts; and sells its products through its network of Green Goods and other Goodness Growth branded retail dispensaries, as well as third-party dispensaries. As of March 11, 2022, it operated 18 dispensaries, which included 2 in Maryland, 8 in Minnesota, 4 in New Mexico, and 4 in New York; and offered wholesale cannabis products through third-party companies in Arizona, Maryland, Minnesota, and New York. The company was formerly known as Vireo Health International Inc. and changed its name to Goodness Growth Holdings, Inc. in June 2021. Goodness Growth Holdings, Inc. is headquartered in Minneapolis, Minnesota.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
GDNSFBeat Rate
25%
Last 12 quarters
Avg Surprise
-34.0%
EPS vs Estimate
Beats / Misses
3/8
1 met exactly
Latest EPS
$-0.03
Q3 2025
EPS Surprise History
Q1 23
-25.0%
$-0.10vs$-0.08
Q3 23
-20.0%
$-0.06vs$-0.05
Q4 23
+20.0%
$-0.04vs$-0.05
Q2 24
0.0%
$-0.03vs$-0.03
Q2 24
-25.0%
$-0.05vs$-0.04
Q2 25
No data
Q2 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Aug 13, 2025 | — | $-0.03 | — | — |
Q2 2025 | May 9, 2025 | — | $-0.02 | — | — |
Q2 2025 | May 5, 2025 | — | $-0.07 | — | — |
Q4 2024 | Nov 12, 2024 | — | — | — | — |
Q3 2024 | Aug 12, 2024 | $-0.03 | — | — | — |
Q2 2024 | May 7, 2024 | $-0.04 | $-0.05 | -25.0% | ✗ MISS |
Q2 2024 | Apr 1, 2024 | $-0.03 | $-0.03 | 0.0% | = MET |
Q4 2023 | Nov 14, 2023 | $-0.05 | $-0.04 | +20.0% | ✓ BEAT |
Q3 2023 | Aug 14, 2023 | $-0.05 | $-0.06 | -20.0% | ✗ MISS |
Q1 2023 | Mar 31, 2023 | $-0.08 | $-0.10 | -25.0% | ✗ MISS |
Q1 2023 | Mar 30, 2023 | $-0.08 | $-0.10 | -29.6% | ✗ MISS |
Q4 2022 | Nov 15, 2022 | $-0.06 | $-0.07 | -16.7% | ✗ MISS |
Q3 2022 | Aug 11, 2022 | $-0.05 | $-0.04 | +20.0% | ✓ BEAT |
Q2 2022 | May 11, 2022 | $-0.06 | $-0.08 | -33.3% | ✗ MISS |
Q1 2022 | Mar 11, 2022 | $-0.03 | $-0.10 | -300.0% | ✗ MISS |
Q4 2021 | Nov 10, 2021 | $-0.02 | $-0.04 | -100.0% | ✗ MISS |
Q3 2021 | Aug 13, 2021 | — | $-0.04 | — | — |
Q2 2021 | May 14, 2021 | — | $-0.06 | — | — |
Q1 2021 | Mar 25, 2021 | — | $-0.12 | — | — |
Q4 2020 | Nov 30, 2020 | $-0.08 | $0.00 | +101.4% | ✓ BEAT |
Latest News
Loading news...
Frequently Asked Questions about GDNSF
What is GDNSF's current stock price?
Goodness Growth Holdings, Inc. (GDNSF) is currently trading at $0.45 per share. The stock has moved +0.00% today.
What is the analyst price target for GDNSF?
The average analyst price target for GDNSF is $0.45, based on 1 analyst.
What sector is Goodness Growth Holdings, Inc. in?
Goodness Growth Holdings, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is GDNSF's market cap?
Goodness Growth Holdings, Inc. has a market capitalization of $0.06 billion, making it a small-cap company.
Does GDNSF pay dividends?
No, Goodness Growth Holdings, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBIOGF
Biocartis Group N.V.
$0.66
Mkt Cap: $0.1B
BSTG
Biostage, Inc.
$4.03
Mkt Cap: $0.1B
EEOIF
Elegance Optical International Holdings Limited
$0.07
Mkt Cap: $0.1B
EOFBY
Ecofibre Limited
$0.84
Mkt Cap: $0.1B
HRPMF
Herantis Pharma Oyj
$3.51
Mkt Cap: $0.1B
INNPF
INNOCAN PHARMA Corp
$7.23
Mkt Cap: $0.0B
KIARF
Kiaro Holdings Corp.
$0.00
Mkt Cap: $0.0B
MCIOF
MCI Onehealth Technologies Inc.
$0.55
Mkt Cap: $0.1B
ONPPF
Oncopeptides AB (publ)
$0.27
Mkt Cap: $0.1B
SYMQY
SymBio Pharmaceuticals Limited
$0.64
Mkt Cap: $0.0B
Explore stocks similar to GDNSF for comparison